A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

NCT00623831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Sarcoma
Gastrointestinal Stromal Tumor (GIST)
Head and Neck Cancer
Transitional Cell Carcinoma
Prostate Cancer
Ovarian Carcinoma
Esophageal Cancer
Breast Cancer

Interventions

BIOLOGICAL: Mixed bacterial vaccine

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]